Redefining the approach to cancer care – a mission to improve patient outcomes Each year across Europe, 3.7 million people are diagnosed with a form of cancer, resulting in 1.9 million Share X Redefining the approach to cancer care – a mission to improve patient outcomes https://pharmaphorum.com/oncology/redefining-the-approach-to-cancer-care-a-mission-to-improve-patient-outcomes/
The value of diverse patient representation and engagement in cancer treatment To improve outcomes for cancer patients and take advantage of the ground-breaking scientific and technological progress made in Share X The value of diverse patient representation and engagement in cancer treatment https://pharmaphorum.com/whitepapers/value-of-diverse-patient-representation-and-engagement-cancer/
Next generation coaching Capturing an audience is a critical task. Doing that in a wind tunnel of multi-channel white noise requires Share X Next generation coaching https://pharmaphorum.com/sales-marketing/next-generation-coaching/
Top 5 takeaways from international hybrid and virtual meeting guidance for pharma The move to online international meetings has left pharma companies with uncertainty around contact compliance. But new joint Share X Top 5 takeaways from international hybrid and virtual meeting guidance for pharma https://pharmaphorum.com/digital/top-5-takeaways-from-international-hybrid-virtual-meeting-guidance/
Find your inner data and take precision marketing to the next level Data is the powerhouse of the pharmaceutical sector. It powers drug discovery, clinical trials, and operational performance. But Share X Find your inner data and take precision marketing to the next level https://pharmaphorum.com/sales-marketing/find-your-inner-data-and-take-precision-marketing-to-the-next-level/
Recent advances in neurological disorders Considerable scientific progress across neurological diseases and disorders was reported at the recent 74th American Academy of Neurology Share X Recent advances in neurological disorders https://pharmaphorum.com/r-d/recent-advances-in-neurological-disorders/
Do pharmaceutical businesses need to rethink what their graduate schemes offer? As the world and the UK continues its march out of the pandemic’s shadow, the pharmaceutical and life Share X Do pharmaceutical businesses need to rethink what their graduate schemes offer? https://pharmaphorum.com/views-and-analysis/do-pharmaceutical-businesses-need-to-rethink-what-their-graduate-schemes-offer/
Adding value through coaching Strategic coaching is bringing rewards across pharma as the industry adjusts to post-pandemic practices and challenges. Field forces Share X Adding value through coaching https://pharmaphorum.com/sales-marketing/adding-value-through-coaching/
Healthcare communication and how it’s changing Engaging, strategic, customer-centric communication is important in any industry, and no industry has been unaffected by the changing Share X Healthcare communication and how it’s changing https://pharmaphorum.com/digital/healthcare-communication-and-how-its-changing/